| CTRI Number |
CTRI/2025/07/091958 [Registered on: 29/07/2025] Trial Registered Prospectively |
| Last Modified On: |
25/07/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Physiotherapy (Not Including YOGA) |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Development of supervised exercise training protocol and comparison with conventional exercises in asymptomatic peripheral arterial disease with type II diabetes mellitus patients on Ankle brachial index, HbA1c, functional capacity and quality of life |
|
Scientific Title of Study
|
Development of supervised exercise training protocol and comparison with conventional exercises in asymptomatic peripheral arterial disease with type II diabetes mellitus patients |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Mayuri Shah |
| Designation |
Associate Professor |
| Affiliation |
Dr. D. Y. Patil College of Physiotherapy |
| Address |
Dr. D.Y.PATIL college of physiotherapy, Sant tukaram nagar, Pimpri
Cardiopulmonary Department
Out patient department
Pune MAHARASHTRA 411018 India |
| Phone |
8087861628 |
| Fax |
|
| Email |
plkshah829@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Roopa Desai |
| Designation |
Professor |
| Affiliation |
Dr. D. Y. Patil College of Physiotherapy |
| Address |
Dr. D.Y.PATIL college of physiotherapy, Sant tukaram nagar, Pimpri
Kinesiology and Movement science department
3rd floor
Pune MAHARASHTRA 411018 India |
| Phone |
9890992383 |
| Fax |
|
| Email |
roopa.desai@dpu.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Roopa Desai |
| Designation |
Professor |
| Affiliation |
Dr. D. Y. Patil College of Physiotherapy |
| Address |
Dr. D.Y.PATIL college of physiotherapy, Sant tukaram nagar, Pimpri
Kinesiology and Movement science department
3rd floor
Pune MAHARASHTRA 411018 India |
| Phone |
9890992383 |
| Fax |
|
| Email |
roopa.desai@dpu.edu.in |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Mayuri R. Shah |
| Address |
Dr. D.Y. Patil College of Physiotherapy, Pimpri, Pune- 411018 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Mayuri R Shah |
Dr. D. Y. Patil College of Physiotherapy |
Out patient department and Cardiopulmonary department Pune MAHARASHTRA |
8087861628
plkshah829@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: I70-I79||Diseases of arteries, arterioles and capillaries, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Supervised exercise training protocol |
Supervised exercise training protocol will be designed and validated using delphi method. Post validation the protocol will be supervised and will include warm up exercises, stretching of major muscles, aerobic exercises, resistance exercises with duration starting with 30 minute session in first week to 45 minute session in twelfth week. Session will be carried for 3 alternate days per week. |
| Comparator Agent |
Walking and Buergers exercises |
Walking on flat surface for 15 min per session in first week proceeding to 45 min in twelfth week. Session will be given for 3 alternate days per week. Since patients will be asymptomatic progression will be based on rate of perceived exertion using borg scale.
Buergers exercises will be given in 3 positions namely elevation, dependent and horizontal. Patients will perform these exercises 3 times a day with 3-6 cycles per maneuver. |
|
|
Inclusion Criteria
|
| Age From |
50.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1.Patients diagnosed by diabetologist with Type II Diabetes Mellitus for more than or equal to 10 years and who will be asymptomatic for symptoms of Peripheral arterial disease
2.Score of 6.5 percent to 11 percent of HbA1C
3.Score of less than 6 on Rapid assessment of Physical Activity
4.Score of 0.5 to less than or equal to 0.9 on 5.Ankle Brachial Index
6.Patients if diagnosed with OA knee, Score on Numeric Pain Rating Scale less than or equal to 3
|
|
| ExclusionCriteria |
| Details |
1.Patient following any kind of exercise regime like going to gym, yoga etc.
2.Patient having addiction of smoking, tobacco, and alcohol intake
3.Patients already having complications like diabetic foot ulcer, amputation, neuropathy with renal failure and symptoms of claudication
4.Known Cardiopulmonary disorders like Bronchial Asthma, COPD, Myocardial Ishchemia, Angina, Coronary artery disease
5.Patients on Anticoagulants |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Ankle Brachial Index
2. HbA1c |
1. Pre treatment
2. After 12 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. 6 minute walk distance
2. SF 36 |
1. Pre treatment
2. After 12 weeks |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
15/09/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="3" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
People with type 2 diabetes
should engage in physical activity regularly and be encouraged to reduce
sedentary time and break up sitting time with frequent activity breaks
according to ACSM criteria 2022. Asymptomatic PAD remains the most common presentation of the disease.
The detailed clinical history, physical changes in the lower leg skin, and
examination of peripheral pulses can provide clues to the diagnosis. For decades, exercise has been
considered a cornerstone of diabetes management, along with diet and
medication.
However, high-quality evidence on the importance of exercise and
fitness in diabetes was lacking until recent years. Exercise can directly improve physiological function by reducing blood glucose
levels, increasing stamina and emotional well-being and increasing circulation. Peripheral artery disease is
independently associated with impaired function, an increased risk of
mortality, and decreased quality of life. RESEARCH
GAP:
1.
Lack of standardized protocol for asymptomatic Peripheral arterial disease with Type II diabetes mellitus patients.
2. Lack
of Randomized control trials in evaluating the efficacy of supervised exercises in asymptomatic Peripheral arterial disease with Type II diabetes mellitus patients.
3.
Need for outcome-based trials to determine if Supervised Exercise Training protocol offers vascular protection in asymptomatic Peripheral arterial disease with Type II diabetes mellitus patients.
4.
Research needed to evaluate outcomes of early Supervised Exercise Training protocol based on Ankle Brachial Index (ABI) screening in
diabetes care.
5.
A lack of Supervised Exercise Training protocol designed for early-stage asymptomatic Peripheral arterial disease for prevention
of further complications due to Type II diabetes mellitus. |